You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 2, February 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Breast Cancer
 •Surgical Oncology
 •Alert me on articles by topic

Mapping a Pathway for Axillary Staging

A Personal Perspective on the Current Status of Sentinel Lymph Node Dissection for Breast Cancer

Armando E. Giuliano, MD
Santa Monica, Calif

Arch Surg. 1999;134:195-199.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN 1972, Haagensen1 illustrated the axillary nodal uptake of a vital blue dye during mastectomy. In 1977 Cabanas2 described the identification of nodal drainage pathways and a sentinel node (SN) from penile cancer. Fifteen years later, at the John Wayne Cancer Institute in Santa Monica, Calif, Morton et al3 introduced intraoperative lymphatic mapping as a minimally invasive, practical means of identifying regional nodal metastases to eliminate routine lymph node dissection in patients with no evidence of metastases from cutaneous melanoma. Our group at the John Wayne Cancer Institute popularized the concept of an SN as the first regional lymph node to receive tumor cells that metastasize along the lymphatic drainage pathway from a primary tumor. The tumor status of this SN should therefore reflect the tumor status of the entire regional lymphatic drainage basin.

In October 1991, we began to test the feasibility of intraoperative lymphatic . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy
Tan et al.
Ann. Surg. Oncol. 2007;14:638-645.
ABSTRACT | FULL TEXT  

Manipulation of the Primary Breast Tumor and the Incidence of Sentinel Node Metastases From Invasive Breast Cancer
Hansen et al.
Arch Surg 2004;139:634-640.
ABSTRACT | FULL TEXT  

The Time Has Come to Change the Algorithm for the Surgical Management of Early Breast Cancer
Hansen et al.
Arch Surg 2002;137:1131-1135.
ABSTRACT | FULL TEXT  

The Illusion of the Learning Phase for Lymphatic Mapping
Tanis et al.
Ann. Surg. Oncol. 2002;9:142-147.
ABSTRACT | FULL TEXT  

Cytokine Profiles of Sentinel Lymph Nodes Draining the Primary Melanoma
Leong et al.
Ann. Surg. Oncol. 2002;9:82-87.
ABSTRACT | FULL TEXT  

Intraoperative Pathologic Evaluation of a Breast Cancer Sentinel Lymph Node Biopsy as a Determinant for Synchronous Axillary Lymph Node Dissection
Kane III et al.
Ann. Surg. Oncol. 2001;8:361-367.
ABSTRACT | FULL TEXT  

Axillary staging of breast cancer and the sentinel node
Cserni
J. Clin. Pathol. 2000;53:733-741.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Procedure in Squamous Cell Carcinoma of the Vulva
Cady
JCO 2000;18:2795-2797.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.